Patient and clinician preferences for biologic treatments for severe uncontrolled asthma: a discrete choice experiment (DCE).
Melissa M RossYen ChungTara CarrChristopher S AmbroseAndrew W LindsleyHannah CollacottAndrea SchulzPooja DesaiPallavi RaneMatthew WilliamsHeather L GelhornPublished in: The Journal of asthma : official journal of the Association for the Care of Asthma (2024)
Asthma treatment preferences are largely driven by treatment efficacy and minimizing the risk of site reactions, although preferences differ between patients and clinicians across other attributes, highlighting the need for shared decision-making and individualized care.
Keyphrases
- chronic obstructive pulmonary disease
- end stage renal disease
- palliative care
- healthcare
- rheumatoid arthritis
- lung function
- chronic kidney disease
- newly diagnosed
- decision making
- prognostic factors
- cystic fibrosis
- patient reported outcomes
- quality improvement
- pain management
- health insurance
- smoking cessation
- affordable care act